LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 37 of 497
Next
>>
>
901 to 925 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	Nintedanib	0.37	uM	LJP6	1	H04	72	hr	1097	2763	3769	0.7330	0.6233
BT-20	Nintedanib	0.37	uM	LJP6	2	H04	72	hr	1097	2789	3769	0.7399	0.6331
BT-20	Nintedanib	0.37	uM	LJP6	3	H04	72	hr	1097	2915	3769	0.7733	0.6802
BT-20	NU7441	0.37	uM	LJP5	1	C10	72	hr	1097	3981	3769	1.0561	1.0791
BT-20	NU7441	0.37	uM	LJP5	2	C10	72	hr	1097	3662	3769	0.9715	0.9598
BT-20	NU7441	0.37	uM	LJP5	3	C10	72	hr	1097	3868	3769	1.0261	1.0368
BT-20	Dactolisib	0.37	uM	LJP5	1	M16	72	hr	1097	1110	3769	0.2945	0.0048
BT-20	Dactolisib	0.37	uM	LJP5	2	M16	72	hr	1097	1016	3769	0.2695	-0.0304
BT-20	Dactolisib	0.37	uM	LJP5	3	M16	72	hr	1097	1035	3769	0.2746	-0.0233
BT-20	NVP-TAE684	0.37	uM	LJP6	1	K16	72	hr	1097	3214	3769	0.8526	0.7921
BT-20	NVP-TAE684	0.37	uM	LJP6	2	K16	72	hr	1097	3553	3769	0.9426	0.9190
BT-20	NVP-TAE684	0.37	uM	LJP6	3	K16	72	hr	1097	3684	3769	0.9773	0.9680
BT-20	Palbociclib	0.37	uM	LJP6	1	E16	72	hr	1097	1788	3769	0.4743	0.2585
BT-20	Palbociclib	0.37	uM	LJP6	2	E16	72	hr	1097	1709	3769	0.4534	0.2289
BT-20	Palbociclib	0.37	uM	LJP6	3	E16	72	hr	1097	1655	3769	0.4391	0.2087
BT-20	PD0325901	0.37	uM	LJP5	1	C04	72	hr	1097	2875	3769	0.7627	0.6653
BT-20	PD0325901	0.37	uM	LJP5	2	C04	72	hr	1097	2990	3769	0.7932	0.7083
BT-20	PD0325901	0.37	uM	LJP5	3	C04	72	hr	1097	2862	3769	0.7592	0.6604
BT-20	PD0325901	0.37	uM	LJP6	1	E04	72	hr	1097	2860	3769	0.7587	0.6596
BT-20	PD0325901	0.37	uM	LJP6	2	E04	72	hr	1097	2774	3769	0.7359	0.6275
BT-20	PD0325901	0.37	uM	LJP6	3	E04	72	hr	1097	2752	3769	0.7301	0.6192
BT-20	PD173074	0.37	uM	LJP6	1	I10	72	hr	1097	3864	3769	1.0251	1.0353
BT-20	PD173074	0.37	uM	LJP6	2	I10	72	hr	1097	4099	3769	1.0874	1.1233
BT-20	PD173074	0.37	uM	LJP6	3	I10	72	hr	1097	3842	3769	1.0192	1.0271
BT-20	PD184352	0.37	uM	LJP5	1	L10	72	hr	1097	4095	3769	1.0863	1.1218

|<
<<
Previous
Page 37 of 497
Next
>>
>
901 to 925 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)